An affinity tool for the isolation of endogenous active mTORC1 from various cellular sources
Yasir H. Ibrahim(Royal National Orthopaedic Hospital), Anders P. Mutvei(Karolinska Institutet)
Cited by 2
Related Papers
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
|Cancer Discovery|2012|622
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
|Annals of Oncology|2018|424
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
|EMBO Molecular Medicine|2018|271
Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability
|Nature Communications|2020|81
Prolonged deprivation of arginine or leucine induces PI3K/Akt-dependent reactivation of mTORC1
|Journal of Biological Chemistry|2022|26